UK markets open in 1 hour 55 minutes

Tri Chemical Laboratories Inc. (22E.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
24.60-2.20 (-8.21%)
At close: 08:02AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 850.89M
Enterprise value 803.09M
Trailing P/E 59.71
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.12
Price/book (mrq)5.35
Enterprise value/revenue 12.10
Enterprise value/EBITDA 29.54

Trading information

Stock price history

Beta (5Y monthly) 1.14
52-week change 374.03%
S&P500 52-week change 329.31%
52-week high 330.80
52-week low 315.40
50-day moving average 326.91
200-day moving average 322.54

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 31
Shares outstanding 532.5M
Implied shares outstanding 633.56M
Float 825.37M
% held by insiders 118.42%
% held by institutions 143.61%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.37
Forward annual dividend yield 41.36%
Trailing annual dividend rate 330.00
Trailing annual dividend yield 3111.94%
5-year average dividend yield 4N/A
Payout ratio 439.46%
Dividend date 3N/A
Ex-dividend date 430 Jan 2025
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Jan 2024
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin 21.96%
Operating margin (ttm)19.17%

Management effectiveness

Return on assets (ttm)3.81%
Return on equity (ttm)9.24%

Income statement

Revenue (ttm)11.25B
Revenue per share (ttm)346.06
Quarterly revenue growth (yoy)-17.30%
Gross profit (ttm)N/A
EBITDA 3.25B
Net income avi to common (ttm)2.47B
Diluted EPS (ttm)0.45
Quarterly earnings growth (yoy)35.80%

Balance sheet

Total cash (mrq)10.5B
Total cash per share (mrq)323.02
Total debt (mrq)2.4B
Total debt/equity (mrq)8.70%
Current ratio (mrq)7.45
Book value per share (mrq)848.36

Cash flow statement

Operating cash flow (ttm)2.97B
Levered free cash flow (ttm)-1.05B